Nexaph peptides represent the new landscape in therapeutic development. These small structures of protein residues present remarkable potential for interacting with difficult processes involved in various diseases. Early investigations demonstrate they can deliver high affinity and show desirable ADME properties, paving ways to novel medicines. Con